Telaprevir Based Antiviral Triple Therapy for HCV Recurrence in Genotype-1 Infected Liver Graft Recipients.

被引：0
|
作者：
Klein, Fritz [1 ]
Neuhaus, Ruth [1 ]
Hofmann, Joerg [2 ]
Guel, Safak [1 ]
Puhl, Gero [1 ]
Neuhaus, Peter [1 ]
Bahra, Marcus [1 ]
机构：
[1] Charite Campus Virchow Univ Med Berlin, Dept Gen Visceral & Transplantat Surg, Berlin, Germany
[2] Charite Campus Mitte Univ Med Berlin, Inst Med Virol, Berlin, Germany
来源：
LIVER TRANSPLANTATION | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 50 条
  • [41] Successful Retreatment of HCV Genotype-1 Infected Patients Who Failed Prior Therapy With Peginterferon plus Ribavirin Plus 1 or 2 Other Direct-Acting Antiviral Agents With Sofosbuvir
    Jacobson, Ira M.
    Sulkowski, Mark
    Hassanein, Tarek
    Ni, Liyun
    Mo, Hongmei
    Kanwar, Bittoo
    Brainard, Diana M.
    Subramanian, G. M.
    Symonds, William T.
    McHutchison, John G.
    Bennett, Michael T.
    Gane, Edward
    GASTROENTEROLOGY, 2014, 146 (05) : S904 - S904
  • [42] SOFOSBUVIR/VELPATASVIR FOR 12 WEEKS IN GENOTYPE 1-4 HCV-INFECTED LIVER TRANSPLANT RECIPIENTS
    Agarwal, Kosh
    Castells, Luis
    Mullhaupt, Beat
    MacDonald, Douglas C.
    McNabb, Brian
    Arterburn, Sarah
    Camus, Gregory
    McNally, John
    Brainard, Diana M.
    Subramanian, G. Mani
    Yip, Christina Sze Man
    Huang, Hai Cheng
    Gonsalkorala, Enoka
    Londono, Maria
    Dufour, Jean-Francois
    Forns, Xavier
    GUT, 2018, 67 : A98 - A99
  • [43] Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients
    Agarwal, Kosh
    Castells, Lluis
    Mullhaupt, Beat
    Rosenberg, William M. C.
    McNabb, Brian
    Arterburn, Sarah
    Camus, Gregory
    McNally, John
    Stamm, Luisa M.
    Brainard, Diana M.
    Subramanian, G. Mani
    Marino, Zoe
    Dufour, Jean-Francois
    Forns, Xavier
    JOURNAL OF HEPATOLOGY, 2018, 69 (03) : 603 - 607
  • [44] Choice of calcineurin inhibitor as well as genotype incluence response to antiviral therapy in liver transplant recipients treated for recurrent HCV.
    Lilly, Leslie B.
    Selzner, Nazia
    Wong, Philip
    Therapondos, George
    Levy, Gary A.
    Cattral, Mark S.
    Greig, Paul D.
    McGilvray, Ian
    Grant, David R.
    Girgrah, Nigel
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 240 - 240
  • [45] Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients
    Agarwal, Kosh
    Castells, Lluis
    Mullhaupt, Beat
    Rosenberg, William M.
    McNabb, Brian L.
    Arterburn, Sarah
    Camus, Gregory
    McNally, John
    Brainard, Diana M.
    Subramanian, Mani
    Gonsalkorala, Enoka
    Londono, Maria
    Dufour, Jean-Francois
    Forns, Xavier
    HEPATOLOGY, 2017, 66 : 571A - 571A
  • [46] Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection
    Picchio, Gaston
    De Meyer, Sandra
    Dierynck, Inge
    Ghys, Anne
    Gritz, Linda
    Kieffer, Tara L.
    Bartels, Douglas J.
    Witek, Jim
    Bengtsson, Leif
    Luo, Donghan
    Kauffman, Robert S.
    Adda, Nathalie
    Sarrazin, Christoph
    JOURNAL OF CLINICAL VIROLOGY, 2014, 59 (03) : 148 - 155
  • [47] Telaprevir-based triple therapy for hepatitis C null responders among living donor liver transplant recipients
    Kaneko, Junichi
    Sugawara, Yasuhiko
    Yamaguchi, Takamune
    Harada, Nobuhiro
    Akamatsu, Nobuhisa
    Ishizawa, Takeaki
    Aoki, Taku
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Tamura, Sumihito
    Tanaka, Tomohiro
    Kokudo, Norihiro
    BIOSCIENCE TRENDS, 2014, 8 (06) : 339 - 345
  • [48] Antiviral therapy for HCV-1b liver transplant recipients:: Better results with younger grafts
    Benlloch, S
    Berenguer, M
    Fernández, A
    Palau, A
    Aguilera, V
    Prieto, M
    Berenguer, J
    HEPATOLOGY, 2005, 42 (04) : 489A - 489A
  • [49] Impact of adherence to triple therapy with telaprevir according to IL28B genotype in Japanese patients infected with chronic hepatitis C genotype 1
    Miyase, Shiho
    Morishita, Yuko
    Haraoka, Katsuki
    Ouchida, Yoshihiro
    Fujiyama, Shigetoshi
    Sasaki, Yutaka
    HEPATOLOGY, 2013, 58 : 1158A - 1158A
  • [50] Treatment of Recurrent Genotype 1 Hepatitis C Post-Liver Transplantation: Single Center Experience with Telaprevir-Based Triple Therapy
    Werner, C. R.
    Egetemeyr, D. P.
    Nadalin, S.
    Koenigsrainer, A.
    Malek, N. P.
    Lauer, U. M.
    Berg, C. P.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (01): : 27 - 34
12345